0 NASDAQ Companies - November 14, 2024Crown Reports Third Quarter 2024 ResultsAchieved Record Quarterly Revenue of $8.0 Million Reiterates Fourth Quarter and Full Year 2024 Revenue Guidance of $9 Million and […]Read More
0 NASDAQ Companies - November 14, 2024EzFill Announces 2024 Third Quarter Financial Results— Revenue Increased 13% Year Over Year to $7.0 Million From $6.2 Million — — Gross Profit Increased 74% From […]Read More
0 NASDAQ Companies - November 14, 2024JBi Digital chooses Rackspace Sovereign Government Cloud for its pursuit of new customers in the UK government services sectorLONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a leading hybrid, multicloud, and AI technology services company, […]Read More
0 NASDAQ Companies - November 14, 2024ZOOZ Power Enters Standby Equity Purchase Agreement to Further Growth StrategyTel Aviv, Israel, Nov. 14, 2024 (GLOBE NEWSWIRE) — ZOOZ Power Ltd. (NASDAQ and TASE: ZOOZ) (“ZOOZ”), the leading provider […]Read More
0 Canadian Stock Exchange News - November 14, 2024PharmAla Reaches Agreement in Principle to Supply MDMA to Clinical Trial in Exchange for Full Data LicenseTORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology […]Read More
0 NASDAQ Companies - November 14, 2024Jamf Achieves Microsoft Azure’s IP Co-Sell Top-Tier Partner Status, Announces Select Solutions Now Available in Azure MarketplaceMINNEAPOLIS , Nov. 14, 2024 (GLOBE NEWSWIRE) — Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, […]Read More
0 NASDAQ Companies - November 14, 2024MIMEDX’s Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDsOver 200 Unproven Skin Substitutes Will No Longer Be Covered Under Revised LCDs Company to Benefit from MACs’ Commitment to […]Read More
0 NASDAQ Companies - November 14, 2024ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent HighlightsPresented full dataset from first-in-human Phase 1a clinical trial demonstrating PMN310 was generally well-tolerated with monthly dosing and that PMN310 […]Read More
0 NASDAQ Companies - November 14, 2024IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1)FRANKLIN, TN, Nov. 14, 2024 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that […]Read More
0 NASDAQ Companies - November 14, 2024Euroseas Ltd. Sets Date for the Release of Third Quarter 2024 Results, Conference Call and WebcastATHENS, Greece, Nov. 14, 2024 (GLOBE NEWSWIRE) — Euroseas Ltd. (NASDAQ: ESEA), an owner and operator of container carrier vessels […]Read More